Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: cyclodextrin polymer

July 7, 2026 CD derivatives / Drug delivery / Pharma applications

Poly-β-Cyclodextrin as a Superior Host for Gemcitabine

Gemcitabine remains a vital chemotherapeutic agent, yet its rapid deamination and short systemic persistence necessitate improved delivery strategies. This study

Continue reading

June 25, 2026 CD derivatives / Drug delivery / Pharma applications

Poly-CD-PEG-camptothecin Combined with Olaparib  in People With Relapsed/​Refractory Small Cell Lung Cancer (Clinical trial)

The authors hypothesized that integrating tumor-targeted topoisomerase I inhibitor delivery with optimized PARP inhibitor scheduling could enable effective combination therapy

Continue reading

May 28, 2026 CD derivatives / Drug delivery / Pharma applications / Uncategorized

PEG-β-Cyclodextrin polymer-based formulation to increase the antiangiogenic activity of rutin in vivo

Rutin (RTN) is a natural flavonoid with well-documented anti-angiogenic, antioxidant, anti-inflammatory, and anti-cancer properties. However, its therapeutic potential is limited

Continue reading

April 7, 2026 Environmental / Non-pharma applications

Sustainable capture and photocatalytic degradation of organic pollutants by high-swelling cyclodextrin polymer loaded with TiO2 nanoparticles

Photocatalytic degradation provides a promising sustainable solution for water purification, but its effectiveness is often limited by the low utilization

Continue reading

February 26, 2026 CD derivatives / Drug delivery / Pharma applications

Cyclodextrin Polymer Complexation Improves the Tolerability of Parenteral Oestradiol

This study investigates the PEG‑β‑CD polymer, a water‑soluble polyethylene glycol–β‑cyclodextrin cross‑linked carrier, as a potential alternative to conventional oestradiol formulations

Continue reading

January 29, 2026 Drug delivery / Pharma applications

Poly(β-cyclodextrin)-coated dysprosium-doped ZnS nanocarriers

This study provides a comprehensive analysis of the structures and properties of zinc sulfide (ZnS) and dysprosium-doped ZnS nanoparticles (NPs)

Continue reading

January 27, 2026 CD as API / Pharma applications

A water-soluble β-cyclodextrin polymer reduces cholesterol accumulation and autophagy dysfunction in vitro and in Niemann-Pick type C disease model mice

A β-CDP (CycloLab) was used for the experiments. The purity of the β-CDP was >95 %. The β-CDP contained <1 % of

Continue reading

December 15, 2025 CD as API / CD derivatives / Pharma applications

Dual activity of low-molecular-weight polymeric β-cyclodextrins against tuberculosis

/The biological properties of pβCD of different molecular weights were studied. Strikingly, only the low-molecular-weight pβCD (LMW-pβCD) displayed antibacterial activity,

Continue reading

December 3, 2025 Environmental / Non-pharma applications / Uncategorized

High-swelling cyclodextrin polymer for sustainable water purification

A high-swelling cyclodextrin polymer (His-CDP) is reported that is facilely synthesized without additional design and templates, to achieve high affinity,

Continue reading

a rat is standing on top of a plastic container
November 24, 2025 CD as API / CD derivatives / Pharma applications

A β-cyclodextrin polymer reduces cholesterol accumulation and mitigates autophagy dysfunction in vitro and in a Niemann–Pick Type C animal model

Niemann–Pick disease type C (NPC) and Alzheimer’s disease (AD) are both characterised by cognitive decline and neurological impairment. In each

Continue reading

Posts pagination

1 2 3 … 5 Next Posts»

Recent Posts

  • Positively Charged Fluorine-Free Cyclodextrin Nanosponges for PFAS Removal
  • Impact of Cholesterol Depletion by methyl BCD on Dopamine Transmission Dynamics in Brain
  • Special Issue “Cyclodextrin-Functionalized Materials for Drug Delivery, Pharmaceutical and Medical Applications”
  • Cyclodextrin-Based Oral Solution of Ursodeoxycholic Acid Using a Ready-to-Use Vehicle
  • Cyclodextrin-based electrochemical sensors for PFAS detection

Tags

alpha-CD Alzheimer disease atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (72)
  • CD as API (351)
  • CD derivatives (423)
  • Cosmetics and toilettry (52)
  • Diagnosis (13)
  • Drug delivery (803)
  • E-ducation (63)
  • Environmental (141)
  • Events (236)
  • Food (229)
  • Gene delivery (22)
  • Household products (5)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (44)
  • Non-pharma applications (409)
  • Other industrial use (110)
  • Pharma applications (1,201)
  • Supramolecular systems (44)
  • Uncategorized (161)

Top Posts

  • Positively Charged Fluorine-Free Cyclodextrin Nanosponges for PFAS Removal
  • CDs for the removal of PFAS; A review
  • Use of odor-absorbing component, Hydroxypropyl-β-cyclodextrin in a new Japanese personal care product
  • How air fresheners work?
  • Impact of Cholesterol Depletion by methyl BCD on Dopamine Transmission Dynamics in Brain
  • FDA Grants Approval to HPBCD-Enhanced Biologic: A 'Super-Originator' Formulation
  • The Impact and Prospects of Green Chemistry for Textile Technology
  • HPBCD treatment for Niemann-Pick C: Mallinckrodt communicated results of clinical trial
  • Cyclo Therapeutics Inc. Commences Commercial-Scale Manufacturing for Trappsol® Cyclo™
  • Cyclodextrins-based sorbents for sustainable sample preparation focusing on food analysis

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,476 other subscribers
Loading Comments...